About Zentalis
We are focused on the creation of differentiated small molecule treatments targeting fundamental biological pathways of cancer. Using our unique chemistry and biological expertise, we have developed an integrated approach to identify and overcome the limitations of current cancer therapeutics, enabling us to design better small molecules for improved patient outcomes.